1. Home
  2. NCRA vs NKGN Comparison

NCRA vs NKGN Comparison

Compare NCRA & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCRA
  • NKGN
  • Stock Information
  • Founded
  • NCRA 2002
  • NKGN 2017
  • Country
  • NCRA Taiwan
  • NKGN United States
  • Employees
  • NCRA N/A
  • NKGN N/A
  • Industry
  • NCRA Farming/Seeds/Milling
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NCRA Consumer Staples
  • NKGN Health Care
  • Exchange
  • NCRA Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • NCRA 11.5M
  • NKGN 22.6M
  • IPO Year
  • NCRA N/A
  • NKGN N/A
  • Fundamental
  • Price
  • NCRA $0.89
  • NKGN $0.70
  • Analyst Decision
  • NCRA
  • NKGN
  • Analyst Count
  • NCRA 0
  • NKGN 0
  • Target Price
  • NCRA N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • NCRA 562.3K
  • NKGN 598.6K
  • Earning Date
  • NCRA 08-14-2024
  • NKGN 01-07-2025
  • Dividend Yield
  • NCRA N/A
  • NKGN N/A
  • EPS Growth
  • NCRA N/A
  • NKGN N/A
  • EPS
  • NCRA N/A
  • NKGN N/A
  • Revenue
  • NCRA $20,483,694.00
  • NKGN N/A
  • Revenue This Year
  • NCRA N/A
  • NKGN N/A
  • Revenue Next Year
  • NCRA N/A
  • NKGN N/A
  • P/E Ratio
  • NCRA N/A
  • NKGN N/A
  • Revenue Growth
  • NCRA N/A
  • NKGN N/A
  • 52 Week Low
  • NCRA $0.70
  • NKGN $0.20
  • 52 Week High
  • NCRA $2.09
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • NCRA 44.48
  • NKGN 64.89
  • Support Level
  • NCRA $0.80
  • NKGN $0.63
  • Resistance Level
  • NCRA $2.09
  • NKGN $0.97
  • Average True Range (ATR)
  • NCRA 0.21
  • NKGN 0.10
  • MACD
  • NCRA 0.00
  • NKGN 0.02
  • Stochastic Oscillator
  • NCRA 11.15
  • NKGN 57.18

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: